VR Logo

Stereotaxis Inc. (STXS) download report


Healthcare | Medical Devices & Equipment

Stereotaxis Inc. (STXS) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

IPO Date: 12-Aug-2004

CEO & Chairman: Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA

CFO & Sec.: Ms. Kimberly R. Peery

Listing: NYSE: STXS

Country: United States

Headquarters: Saint Louis, MO

Website: https://www.stereotaxis.com

Key Facts

Market cap: $141.86 Mln

Revenue (TTM): $33.44 Mln

Earnings (TTM): $-14.27 Mln

Cash: $35.10 Mln

Total Debt: $6.05 Mln

Insider's Holding: 15.43%

Liquidity: Low

52 Week range: $1.72 - 10.09

Shares outstanding: 74,661,600

10 Years Aggregate:

  • CFO: $-54.93 Mln
  • EBITDA: $-58.02 Mln
  • Net Profit: $-123.56 Mln

Stock Performance

Time Period Stereotaxis (STXS) S&P BSE Sensex S&P Small-Cap 600
YTD-70.16-9.18-18.78
1 month-16.29-4.78-8.00
3 months-50.40-9.66-13.65
1 Year-80.810.81-17.19
3 Years-13.9210.336.10
5 Years26.1111.345.87
10 Years-0.6311.749.84
As on 01-Jul-2022
Year Stereotaxis (STXS) S&P Small-Cap 600 S&P BSE Sensex
202121.8125.2721.99
2020-3.789.5715.75
2019389.3620.8614.38
201834.90-9.705.87
201723.1011.7327.91
2016-12.5824.741.95
2015-49.77-3.36-5.03